Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
KING OF PRUSSIA, Pa., Sept. 23, 2025 /PRNewswire/ — CluePoints, the premier sponsor of RBQMLive and...
- Featured Article
Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review,...
Source: Contract Pharma
- Featured Article
As a follow-up to Clinical Trials Day 2025, held on May 20 with the theme of...
Source: The Association of Clinical Research Professionals
- Featured Article
“Identifying … potential data manipulation and data integrity problems” are an International Council for Harmonization of...
Source: Applied Clinical Trials
- Featured Article
Artificial Intelligence (AI) continues to gain momentum in the pharmaceutical sector, but can it truly deliver...
Source: Health Tech World
- Featured Article
Dr Laura Trotta gives us an insight into her role at CluePoints and shares some of...
Source: Health Tech World
- Featured Article
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable...
Source: ONdrugDelivery
- Featured Article
Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven...
Source: European Medical Journal GOLD
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Press Release
King of Prussia, PA – January 12, 2026 – CluePoints, provider of leading statistical and AI-driven...
- Press Release
CluePoints Scoops Prestigious 2025 Scrip Award RBQM and AI leader wins the ‘Best Contract Research Organization...
- Press Release
King of Prussia, PA – November 5th, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
The RBQM and AI leader wins the ‘Clinical Data Science Implementation Excellence Award’ at SCDM 2025...
- Press Release
KING OF PRUSSIA, Pa., Sept. 23, 2025 /PRNewswire/ — CluePoints, the premier sponsor of RBQMLive and...
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Press Release
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at...
- Featured Article
The pharmaceutical industry has a problem – a failure to provide women with C-suite opportunities.
...Source: International Clinical Trials
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link
